Indirect CD4+ TH1 response, antidonor antibodies and diffuse C4d graft deposits in long-term recipients conditioned by donor antigens priming

American Journal of Transplantation

Volumn 9, Issue 4, 2009, Pages 697-708

  Ballet, C ^a   Renaudin, K ^b   Degauque, N ^a   Mai, H L ^a   Boeffard F ^a   Lair, D ^a   Berthelot, L ^a   Feng, C ^a   Smit, H ^a   Usal, C ^a   Heslan, M ^a   Josien, R ^a   Brouard, S ^a   Soulillou, J P ^a  

^a INSERM   (France)

^b HÔTEL DIEU   (France)

Author keywords

Alloantibodies; Allotransplantation; Antibody mediated rejection; Chronic allograft rejection; Complement C4d; Heart allograft; Transplantation

Indexed keywords

COMPLEMENT COMPONENT C4D; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ACUTE GRAFT REJECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; BLOOD VESSEL; CARDIAC GRAFT REJECTION; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CELLULAR IMMUNITY; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; ENDARTERITIS; FIBROSIS; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART GRAFT; HEART TRANSPLANTATION; HELPER CELL; HUMORAL IMMUNITY; LEUKOCYTE; LEWIS RAT; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY T LYMPHOCYTE; TH1 CELL;

EID: 63349106821     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02556.x     Document Type: Article

References (42)

1. Haspot F, Seveno C, Dugast AS et al. Anti-CD28 antibody-induced kidney allograft tolerance related to tryptophan degradation and TCR class II B7 regulatory cells. Am J Transplant 2005 5 : 2339 2348.
2. Guillonneau C, Seveno C, Dugast AS et al. Anti-CD28 antibodies modify regulatory mechanisms and reinforce tolerance in CD40Ig-treated heart allograft recipients. J Immunol 2007 179 : 8164 8171.
3. Trikudanathan S, Sayegh MH. The evolution of the immunobiology of co-stimulatory pathways: clinical implications. Clin Exp Rheumatol 2007 25 (5 Suppl 46 S12 21.
4. +Foxp3+ regulatory T lymphocytes. Nat Med 2008 14 : 88 92.
5. Koshiba T, Kitade H, Van Damme B et al. Regulatory cell-mediated tolerance does not protect against chronic rejection. Transplantation 2003 76 : 588 596.
6. Heslan JM, Renaudin K, Thebault P, Josien R, Cuturi MC, Chiffoleau E. New evidence for a role of allograft accommodation in long-term tolerance. Transplantation 2006 82 : 1185 1193.
7. Guillonneau C, Hill M, Hubert FX et al. CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase. J Clin Invest 2007 117 : 1096 1106.
8. Lair D, Degauque N, Miqueu P et al. Functional compartmentalization following induction of long-term graft survival with pregraft donor-specific transfusion. Am J Transplant 2007 7 : 538 549.
9. Josien R, Pannetier C, Douillard P et al. Graft-infiltrating T helper cells, CD45RC phenotype, and Th1/Th2-related cytokines in donor-specific transfusion-induced tolerance in adult rats. Transplantation 1995 60 : 1131 1139.
10. Solez K, Colvin RB, Racusen LC et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008 8 : 753 760.
11. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969 57 : 225 229.
12. Soulillou JP, Blandin F, Gunther E, Lemoine V. Genetics of the blood transfusion effect on heart allografts in rats. Transplantation 1984 38 : 63 67.
13. van Denderen B, Peche H, Gagne K, Usal C, Cuturi MC, Soulillou JP. Identification of immunodominant donor MHC peptides following rejection and donor strain transfusion-induced tolerance of heart allografts in adult rats. Eur J Immunol 2001 31 : 1333 1339.
14. Thaunat O, Field AC, Dai J et al. Lymphoid neogenesis in chronic rejection: Evidence for a local humoral alloimmune response. Proceedings of the National Academy of Sciences of the United States of America 2005 102 : 14723 14728.
15. Minami K, Murata K, Lee CY et al. C4d deposition and clearance in cardiac transplants correlates with alloantibody levels and rejection in rats. Am J Transplant 2006 6 (5 Pt 1 923 932.
16. Pirenne J, Kitade H, Kawai M et al. Regulatory cells, TH1/TH2 unbalance, and antibody-induced chronic rejection in operational tolerance induced by donor-specific blood transfusion. Transplantation 2005 79 (3 Suppl S25 27.
17. Ashton-Chess J, Brouard S, Soulillou JP. Is clinical tolerance realistic in the next decade? Transpl Int 2006 19 : 539 548.
18. Degauque N, Lair D, Braudeau C et al. Development of CD25- regulatory T cells following heart transplantation: Evidence for transfer of long-term survival. Eur J Immunol 2007 37 : 147 156.
19. Jovanovic V, Lair D, Soulillou JP, Brouard S. Transfer of tolerance to heart and kidney allografts in the rat model. Transpl Int 2008 21 : 199 206.
20. Cunningham DA, Dunn MJ, Yacoub MH, Rose ML. Local production of cytokines in the human cardiac allograft. A sequential study. Transplantation 1994 57 : 1333 1337.
21. Nast CC, Zuo XJ, Prehn J, Danovitch GM, Wilkinson A, Jordan SC. Gamma-interferon gene expression in human renal allograft fine-needle aspirates. Transplantation 1994 57 : 498 502.
22. D'Elios MM, Josien R, Manghetti M et al. Predominant Th1 cell infiltration in acute rejection episodes of human kidney grafts. Kidney Int 1997 51 : 1876 1884.
23. Benichou G, Takizawa PA, Olson CA, McMillan M, Sercarz EE. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med 1992 175 : 305 308.
24. Watschinger B, Gallon L, Carpenter CB, Sayegh MH. Mechanisms of allo-recognition. Recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells. Transplantation 1994 57 : 572 576.
25. Gallon L, Watschinger B, Murphy B, Akalin E, Sayegh MH, Carpenter CB. The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression. Transplantation 1995 59 : 612 616.
26. + T cell and B cell responses after cardiac allograft rejection. Transplantation 1995 59 : 401 410.
27. Liu Z, Colovai AI, Tugulea S et al. Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest 1996 98 : 1150 1157.
28. Najafian N, Salama AD, Fedoseyeva EV, Benichou G, Sayegh MH. Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: Potential novel assay for prediction of outcomes for renal transplant recipients. J Am Soc Nephrol 2002 13 : 252 259.
29. Josien R, Heslan M, Brouard S, Soulillou JP, Cuturi MC. Critical requirement for graft passenger leukocytes in allograft tolerance induced by donor blood transfusion. Blood 1998 92 : 4539 4544.
30. Roussey-Kesler G, Brouard S, Ballet C et al. Exhaustive depletion of graft resident dendritic cells: Marginally delayed rejection but strong alteration of graft infiltration. Transplantation 2005 80 : 506 513.
31. Sayegh MH, Khoury SJ, Hancock WW, Weiner HL, Carpenter CB. Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat. Proceedings of the National Academy of Sciences of the United States of America 1992 89 : 7762 7766.
32. Sayegh MH, Perico N, Imberti O, Hancock WW, Carpenter CB, Remuzzi G. Thymic recognition of class II major histocompatibility complex allopeptides induces donor-specific unresponsiveness to renal allografts. Transplantation 1993 56 : 461 465.
33. Vella JP, Magee C, Vos L et al. Cellular and humoral mechanisms of vascularized allograft rejection induced by indirect recognition of donor MHC allopeptides. Transplantation 1999 67 : 1523 1532.
34. Bugeon L, Cuturi MC, Hallet MM, Paineau J, Chabannes D, Soulillou JP. Peripheral tolerance of an allograft in adult rats-characterization by low interleukin-2 and interferon-gamma mRNA levels and by strong accumulation of major histocompatibility complex transcripts in the graft. Transplantation 1992 54 : 219 225.
35. Gagne K, Brouard S, Guillet M, Cuturi MC, Soulillou JP. TGF-beta1 and donor dendritic cells are common key components in donor-specific blood transfusion and anti-class II heart graft enhancement, whereas tolerance induction also required inflammatory cytokines down-regulation. Eur J Immunol 2001 31 : 3111 3120.
36. Vella JP, Spadafora-Ferreira M, Murphy B et al. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 1997 64 : 795 800.
37. Crespo-Leiro MG, Veiga-Barreiro A, Domenech N et al. Humoral heart rejection (severe allograft dysfunction with no signs of cellular rejection or ischemia): Incidence, management, and the value of C4d for diagnosis. Am J Transplant 2005 5 : 2560 2564.
38. Smith RN, Brousaides N, Grazette L et al. C4d deposition in cardiac allografts correlates with alloantibody. J Heart Lung Transplant 2005 24 : 1202 1210.
39. Chantranuwat C, Qiao JH, Kobashigawa J, Hong L, Shintaku P, Fishbein MC. Immunoperoxidase staining for C4d on paraffin-embedded tissue in cardiac allograft endomyocardial biopsies: Comparison to frozen tissue immunofluorescence. Appl Immunohistochem Mol Morphol 2004 12 : 166 171.
40. Rodriguez ER, Skojec DV, Tan CD et al. Antibody-mediated rejection in human cardiac allografts: Evaluation of immunoglobulins and complement activation products C4d and C3d as markers. Am J Transplant 2005 5 : 2778 2785.
41. Qian Z, Lee CY, Murata K et al. Antibody and complement mediated injury in transplants following sensitization by allogeneic blood transfusion. Transplantation 2006 82 : 857 864.
42. Ashton-Chess J, Giral M, Mengel M et al. Tribbles-1 as a novel biomarker of chronic antibody-mediated rejection. J Am Soc Nephrol 2008 19 : 1116 1127.